For example, we have shown that the self-renewal capacity of pancreatic cancer stem cells is dependent on both Hedgehog and mTOR signaling, and simultaneous targeting of these two pathways, in combination with Gemcitabine, represents a novel treatment strategy for epithelial cancers such as pancreatic cancer [9]. Here, MTOR is linked to pancreatic neoplasm.